accux-qa
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
CMA Member Access
CMA Members please log in below using your CMAJ account.
If you don't remember your CMAJ login, click here to reset it.
If you don't have a CMAJ account and know your CMA membership number, click here to create an account. If you don't know your CMA membership number, contact the Member Service Centre via telephone at 888-855-2555 ext. 8004 (Canada & Continental US only); 613-731-8610 ext. 8004 or via email at memberservicecentre@cma.ca.
Log in using your username and password
Log in through your institution
You may be able to gain access using your login credentials for your institution. Contact your library if you do not have a username and password.
In this issue
Article tools
Respond to this article
Vaccination in adults with autoimmune rheumatic diseases
Jump to section
- Article
- Vaccination status should be assessed at diagnosis and periodic examinations in patients with rheumatic diseases
- Inactivated vaccines are safe and generally effective in patients receiving disease-modifying antirheumatic drugs
- Ideally, vaccination administration should be completed before treatment and during stable disease, but do not unduly delay or hold DMARD treatment
- Live vaccines should be avoided in patients receiving biologic DMARDs
- All vaccinations can be given on the same day
- Footnotes
- References
- Figures & Tables
- Related Content
- Responses
- Metrics
Related Articles
Cited By...
- No citing articles found.